stockmarketnews.online EDGAR snapshot
The Filings Docket Corporate filings, explained: what large U.S. companies filed with the SEC, and what it means.

In re: BRISTOL MYERS SQUIBB CO · CIK 0000014272

When will Bristol Myers Squibb Co file its next 10-Q?

BMY · NYSE, NYSE
Snapshot

Bristol Myers Squibb Co is expected to file its next quarterly report (Form 10-Q), for the period ending about Sept. 30, 2026, between Oct. 26, 2026 and Nov. 2, 2026, based on its last 8 10-Q filings. The SEC deadline for a large accelerated filer is Nov. 9, 2026.

How the next-report window is calculated

Bristol Myers Squibb Co's most recent periodic report on file is a Form 10-Q for the period ended June 30, 2026, filed July 30, 2026. Its fiscal year ends around Dec. 31, so the next period should close about Sept. 30, 2026, and that report is a Form 10-Q.

SEC rules give a large accelerated filer 40 days after period end to file a 10-Q, which lands on Nov. 9, 2026 after moving off weekends and federal holidays. Over its last 8 10-Qs, Bristol Myers Squibb Co filed between 24 and 31 days after period end (median 30 days), which gives the expected window above. Period ends are estimated from the company's own calendar and may shift by a few days in 52/53-week fiscal years.

Bristol Myers Squibb Co: days from period end to 10-Q/10-K filing 10-Q for period ended 2024-09-30: filed 31 days later; 10-K for period ended 2024-12-31: filed 43 days later; 10-Q for period ended 2025-03-31: filed 24 days later; 10-Q for period ended 2025-06-30: filed 31 days later; 10-Q for period ended 2025-09-30: filed 30 days later; 10-K for period ended 2025-12-31: filed 42 days later; 10-Q for period ended 2026-03-31: filed 30 days later; 10-Q for period ended 2026-06-30: filed 30 days later. 10-Q due: 40d 10-K due: 60d 10-Q · Sept. 30 24 31d 10-K · Dec. 31 24 43d 10-Q · March 31 25 24d 10-Q · June 30 25 31d 10-Q · Sept. 30 25 30d 10-K · Dec. 31 25 42d 10-Q · March 31 26 30d 10-Q · June 30 26 30d days from period end to filing date →

Recent filings by Bristol Myers Squibb Co

Most recent 25 filings excluding insider Forms 3/4/5/144 · SEC EDGAR, retrieved Oct. 16, 2026
FiledFormWhat it isDocument
13G Ownership above 5% by a passive or institutional investor Open SCHEDULE 13G filed 2026-08-07 · Index 0000093751-26-000422
10-Q Quarterly report with unaudited financial statements for the period ended June 30, 2026 Open 10-Q filed 2026-07-30 · Index 0000014272-26-000020
8-K Released earnings or financial results; information shared under Regulation FD Open 8-K filed 2026-07-30 · Index 0000014272-26-000018
11-K Annual report of an employee stock purchase or savings plan Open 11-K filed 2026-06-05 · Index 0000014272-26-000016
11-K Annual report of an employee stock purchase or savings plan Open 11-K filed 2026-06-05 · Index 0000014272-26-000015
11-K Annual report of an employee stock purchase or savings plan Open 11-K filed 2026-06-05 · Index 0000014272-26-000014
S-8 Registration of shares for employee benefit plans Open S-8 filed 2026-05-08 · Index 0001140361-26-020060
8-K Reported shareholder vote results Open 8-K filed 2026-05-08 · Index 0001140361-26-020036
10-Q Quarterly report with unaudited financial statements for the period ended March 31, 2026 Open 10-Q filed 2026-04-30 · Index 0000014272-26-000010
8-K Released earnings or financial results; information shared under Regulation FD Open 8-K filed 2026-04-30 · Index 0000014272-26-000008
13G Ownership above 5% by a passive or institutional investor Open SCHEDULE 13G filed 2026-04-29 · Index 0002100119-26-000248
DEFA14A Additional proxy soliciting materials Open DEFA14A filed 2026-04-17 · Index 0001140361-26-015377
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-03-26 · Index 0000102909-26-000896
ARS Annual report delivered to shareholders Open ARS filed 2026-03-25 · Index 0001140361-26-011149
DEFA14A Additional proxy soliciting materials Open DEFA14A filed 2026-03-25 · Index 0001140361-26-011110
DEF 14A Definitive proxy statement for a shareholder meeting Open DEF 14A filed 2026-03-25 · Index 0000014272-26-000006
10-K Annual report with audited financial statements for the period ended Dec. 31, 2025 Open 10-K filed 2026-02-11 · Index 0000014272-26-000004
8-K Released earnings or financial results; information shared under Regulation FD Open 8-K filed 2026-02-05 · Index 0000014272-26-000002
8-K Information shared under Regulation FD Open 8-K filed 2026-01-12 · Index 0001140361-26-000929
8-K Other events the company chose to report Open 8-K filed 2025-11-18 · Index 0001140361-25-042607
8-K Other events the company chose to report Open 8-K filed 2025-11-10 · Index 0001140361-25-041380
8-K Other events the company chose to report Open 8-K filed 2025-11-03 · Index 0001140361-25-040066
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2025-10-31 · Index 0000019617-25-001051
10-Q Quarterly report with unaudited financial statements for the period ended Sept. 30, 2025 Open 10-Q filed 2025-10-30 · Index 0000014272-25-000149
8-K Released earnings or financial results; information shared under Regulation FD Open 8-K filed 2025-10-30 · Index 0000014272-25-000147

What Bristol Myers Squibb Co's 8-Ks were about in the past year

Bristol Myers Squibb Co filed 9 Form 8-K current reports between Oct. 17, 2025 and Oct. 16, 2026. Each report lists the item numbers it covers; the counts below show how often each item appeared.

ItemMeaningTimes
9.01Financial Statements and Exhibits8
7.01Regulation FD Disclosure5
2.02Results of Operations and Financial Condition4
8.01Other Events3
5.07Submission of Matters to a Vote of Security Holders1

See what each 8-K item means.